Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Skin Neoplasms 6Neoplasms 6Melanoma 5Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Squamous Cell 4Neoplasm Metastasis 3Prostatic Neoplasms 2Lung Neoplasms 2Colonic Neoplasms 2Carcinoma, Merkel Cell 2Advanced Non-Small Cell Lung Cancer 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Sarcoma 1Resectable Non-small Cell Lung Cancer 1Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck 1Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Multiple Myeloma 1Mouth Neoplasms 1Motor Activity 1Liposarcoma 1Laryngeal Neoplasms 1Kidney Neoplasms 1

Interventions

Exercise 22Surveys and Questionnaires 3Resistance Training 3Diet 3Control Groups 3Nutrition Assessment 2Methods 2Interviews as Topic 2High-Intensity Interval Training 2Exercise Therapy 2Counseling 2pertuzumab 1pembrolizumab 1cytisine 1cemiplimab 1avelumab 1Weights and Measures 1Trastuzumab 1Therapeutics 1Telemedicine 1Standard of Care 1Spirometry 1Rehabilitation 1Psychiatric Rehabilitation 1Palliative Care 1Paclitaxel 1Nivolumab 1Neoadjuvant Therapy 1Ipilimumab 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Motor Activity × cemiplimab × Clear all
NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting
22 enrolled
Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡